Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)

The principle purpose of this multicenter trial is to determine the definition, timing and the percentage of nosocomial RSV epidemics throughout Turkey. In addition, secondary purpose of the trial is to determine the prevention strategies of further spread of Respiratory Syncytial Virus (RSV) in the neonatal intensive care unit (NICU).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Syncytial Virus Infections Infections Infections, Epidemics Mononegavirales Infections Paramyxoviridae Infections Pneumovirus Infections RNA Virus Infections Virus Diseases

Age range

5 day–90 day

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara University School of Medicine, Department of Pediatrics, Division of Neonatology

Ankara, 06100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Confirmed RSV infection with either RSV-strip test or polymerase chain reaction (PCR).
Admission to the NICU or hospitalized in the NICU between 1 October 2013 and 01 April 2014.

Exclusion criteria

Refused informed consent

Treatment and study plan

Primary outcomes

Hospitalized Respiratory Syncytial Virus infected Newborn in the Neonatal Intensive Care Units, and its relation with possible epidemics.

Time frame: Patients will be followed during hospitalization, with expected average of 3 weeks

Secondary outcomes

Mortality

Time frame: Patients will be followed during hospitalization, with expected average of 3 weeks

mortality related to RSV infection and epidemics

Sponsors and collaborators

Lead sponsor

Ankara University

Other

Registry information

Official study title

Management of Hospitalized Respiratory Syncytial Virus (RSV) Infected Patients in the Neonatal Intensive Care Unit (NICU) and Control of Epidemics; TurkNICU-RSV Study: A Multicentric, Prospective Trial

Acronym: TurkNICU-RSV

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: Aug 2, 2013
Registry last updated: Jan 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed